Drugs / AER101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07631299 | Jun → Dec 2026 expected | non-small cell lung carcinoma | University of Oklahoma | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AER101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07631299 ↗ |